Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-22-021182

See Remarks acquired 3,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Beetham Thomas W. See Remarks 2022-05-31 Grant or award +3,000 $0.99 $2,970 16,897 D
Loading xslF345X03/doc4.xml…